SETD1A and breast cancer: SETD1A, which methylates H3K4, plays key roles in cancer progression, including in colorectal and breast cancers (Shilatifard, 2012; Salz et al., 2014, 2015; Tajima et al., 2015), and sorafenib resistance (Wu et al., 2020a).